• imdigo-mail
  • United-KingdomGermanyIsrael

    Products

    Cultivating Unique Medicinal Strains while catering to client specific needs.
    Our research group will work in close collaboration with our clients, providing them with patient specific products that focus on one or more of the active ingredients in cannabis.
    Production is initially focused on seven cannabis strains, chosen based on three primary factors:

    Horticulture Suitability

    As judged on multiple criteria including,

    1. Yield
    2. Resilience to pathogens
    3. Proven performance in recirculating deep water culture environments.

    CBD to THC ratio

    Each strain has a carefully chosen ratio of CBD to THC:

    1. High THC, Low CBD
    2. High CBD, Low THC
    3. Balanced THC and CBD

    Our Products


    Strain A is a sativa dominant variety with high CBD levels(13.552 %) and low THC levels(always below 1%). It’s a non-psychoactive variety offering medical benefits without the high, delivering a strong body effect and a calming, anti-anxiety experience.

    Strain B is a CBD rich variety. Ratio of CBD:THC is between 1:1 and 4:1. The variety has a mix of indica and sativa genetics but the growth pattern generally shows an indica dominant appearance with good yields and a satisfying flavour.

    Strain C is a cannabis hybrid created from a careful selection of genetics with high CBG and super low THC levels. The result is a non-psychoactive cannabis plant (cannabigerol is a non-psychoactive cannabinoid) that boasts numerous medical properties.

    Strain D is one of the most potent cannabis strains. It is a strong plant that grows quickly and is suitable for all grow techniques. Strain D is known for its high yields and excellent bud quality.

    Strain E is an Indica dominant hybrid cannabis strain. She is relatively compact cannabis plant with good internodal distance and beautiful large flowers. This strain is able to flower quickly.

    Strain F has a 1:1 ratio of CBD:THC. This strain produces strong, robust plants that do well indoors or for growing in a controlled greenhouse. This CBD cannabis strain is known for high quality and high yield.

    Strain G is a THC-rich cannabis strain. This strain is a good all-rounder, suitable for all growth techniques and systems. She delivers heavy yields in a relatively short flowering time of approximately 9 weeks.

    As a Licensed Producer, our unique Medicinal Varieties along with our quality management system, ensure that our products and processes are leading edge, resulting in unparalleled levels of patient safety and satisfaction.

    Indigo’s integrated activities focus on delivering quality, compassionate patient care and contribute to the development of innovative approaches to ensure accurate and timely delivery of effective medicinal cannabis through collaborative efforts in research and education.


    Indigo Horizon was incorporated in 2019, dedicated to the research, cultivation, processing and distribution of medicinal cannabis to pharmaceutical companies worldwide, with it’s primary focus being the European Market

    Certification


    Copyright by Indigo Horizon 2022. All rights reserved.